IFG Advisory LLC boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,515 shares of the company’s stock after buying an additional 506 shares during the quarter. IFG Advisory LLC’s holdings in Cardinal Health were worth $821,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the business. Amundi Pioneer Asset Management Inc. grew its stake in Cardinal Health by 19.8% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 317,924 shares of the company’s stock valued at $15,307,000 after buying an additional 52,482 shares during the last quarter. Wealth Alliance lifted its holdings in Cardinal Health by 21.0% during the 3rd quarter. Wealth Alliance now owns 7,271 shares of the company’s stock worth $341,000 after purchasing an additional 1,262 shares during the last quarter. OLD Mission Capital LLC bought a new stake in Cardinal Health in the 3rd quarter valued at $1,407,000. Schonfeld Strategic Advisors LLC grew its holdings in Cardinal Health by 2.6% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 37,958 shares of the company’s stock valued at $1,782,000 after buying an additional 950 shares in the last quarter. Finally, Chiron Capital Management LLC bought a new position in Cardinal Health during the 3rd quarter worth $404,000. Hedge funds and other institutional investors own 82.62% of the company’s stock.
Several equities analysts have weighed in on CAH shares. Wolfe Research raised Cardinal Health from an “underperform” rating to a “peer perform” rating in a report on Friday, January 8th. TheStreet upgraded shares of Cardinal Health from a “c” rating to a “b” rating in a research note on Friday, February 5th. Finally, Morgan Stanley dropped their target price on shares of Cardinal Health from $66.00 to $64.00 and set an “equal weight” rating for the company in a research report on Tuesday, March 9th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $60.89.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, February 4th. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.30. The company had revenue of $41.54 billion during the quarter, compared to analysts’ expectations of $41.44 billion. Cardinal Health had a return on equity of 123.28% and a net margin of 0.63%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.52 earnings per share. Sell-side analysts forecast that Cardinal Health, Inc. will post 5.81 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, April 15th. Stockholders of record on Thursday, April 1st were given a $0.4859 dividend. The ex-dividend date was Wednesday, March 31st. This represents a $1.94 dividend on an annualized basis and a dividend yield of 3.20%. Cardinal Health’s dividend payout ratio (DPR) is currently 35.60%.
Cardinal Health Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical.
Further Reading: Rule of 72
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.